
About Almirall
Almirall is a leading global pharmaceutical company based in Barcelona, focused on medical dermatology. Every day, we partner with health care providers and apply science to deliver meaningful medical solutions for patients today and for future generations.

Transforming the patients' world
Our purpose is simple yet ambitious: transform the patients’ world by helping them realize their hopes and dreams for a healthy life.
Our efforts are focused on understanding the real impact skin diseases have on people’s lives.
What do we do?
We don’t just focus on symptoms, but also on how they may affect self-esteem, social relationships, and overall well-being. This patient-centered vision guides our research and development, from early discovery to the medicines and treatments that eventually reach patients.
We also work hand in hand with dermatologists and patients, listening to their needs and integrating their insights into our solutions. By fostering close collaboration and continuous medical education, we help ensure that innovation reaches everyday practice and that patients benefit from the latest scientific advances.




Almirall at a glance
Discover what defines us as a company.
15
Affiliates
0
Affiliates
+0
Employees
0
Nationalities
+0
Countries
0.0%
Of Net Sales Invested in R&D
Some of our major milestones
These are some of the moments that have defined Almirall’s history.


















Foundation of Laboratory Almirall, S.A

About Almirall, LLC - U.S.
Company details
Almirall, LLC - U.S. is headquartered in Malvern, Pennsylvania. Our acne, actinic keratosis and dermatitis medicines are trusted by healthcare professionals and patients nationwide.
Leadership team
The professional experience, educational preparation, energy, and enthusiasm of our US leadership team helps to explain our success.
David Loughery
Chief Financial Officer of Almirall, LLC
30+ years of pharmaceutical experience at Rhone-Poulenc Rorer, Bristol-Myers Squibb, and Teva. B.A. in Economics, Rutgers University and M.B.A. in Finance, Temple University.

Paul Rittman
President and General Manager of Almirall, LLC
Paul Rittman is President and General Manager of Almirall US, where he leads the company's U.S. dermatology business and serves on Almirall's global Management Board. A pharmaceutical executive with more than 35 years of experience, he has held leadership roles spanning sales, marketing, commercial leadership and general management, including more than a decade leading business units in the U.S. and Canada. Before joining Almirall in 2024, Paul was President and CEO of Helsinn Therapeutics US and SVP and General Manager of U.S. Oncology at Teva. He holds a BA from the University of Missouri and an MBA from St. Ambrose University.










Financial reports
Almirall is a public company listed on the BME Spanish stock exchange.
View our annual and other financial reports at almirall.us/investors.
For business development and partnership opportunities, please email Derick Diaz: derick.diaz@almirall.com
